glp-1 medications in the workplace are changing healthcare costs — but medication alone isn't full solution. At Kelly's Choice, our 24-week GLP-1 nutrition education series is designed to support employees both on and Employer FAQs on the Rise

Weight loss remains a central therapeutic driver: A reduction in body weight of at least 7 to 10 percent resolves NASH in approximately 65 to 90 percent of patients

Figure 28: Photograph of the gastrointestinal researchers at Bispebjerg Hospital in 1975, credit: Figure 1.3.3, Holst 2024

There is no question that generic manufacturers are preparing for launch as soon as the Novo data exclusivity expires in January 2026

Furthermore, noted that GLP-1RAs can increase cholesterol excretion and reduce cholesterol accumulation by promoting the expression of ATP-binding cassette transporter A1 (ABCA1) in the endothelium

However, excessive muscle loss can be detrimental to metabolism , strength , and overall health